The microbiota-gut-brain axis JF Cryan, KJ O'Riordan, CSM Cowan, KV Sandhu, TFS Bastiaanssen, ... Physiological reviews, 2019 | 3680 | 2019 |
The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective S Cussotto, KV Sandhu, TG Dinan, JF Cryan Frontiers in neuroendocrinology 51, 80-101, 2018 | 323 | 2018 |
Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function S Cussotto, CR Strain, F Fouhy, RG Strain, VL Peterson, G Clarke, ... Psychopharmacology 236, 1671-1685, 2019 | 277 | 2019 |
Psychotropics and the microbiome: a chamber of secrets… S Cussotto, G Clarke, TG Dinan, JF Cryan Psychopharmacology 236 (5), 1411-1432, 2019 | 157 | 2019 |
Gutted! Unraveling the role of the microbiome in major depressive disorder TFS Bastiaanssen, S Cussotto, MJ Claesson, G Clarke, TG Dinan, ... Harvard Review of Psychiatry 28 (1), 26-39, 2020 | 151 | 2020 |
Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation S Cussotto, I Delgado, A Anesi, S Dexpert, A Aubert, C Beau, D Forestier, ... Frontiers in immunology 11, 557, 2020 | 142 | 2020 |
The gut microbiome influences the bioavailability of olanzapine in rats S Cussotto, J Walsh, AV Golubeva, AV Zhdanov, CR Strain, F Fouhy, ... EBioMedicine 66, 2021 | 49 | 2021 |
Low omega‐3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder S Cussotto, I Delgado, G Oriolo, J Kemper, D Begarie, S Dexpert, ... Depression and Anxiety 39 (5), 407-418, 2022 | 18 | 2022 |
Association between the indole pathway of tryptophan metabolism and subclinical depressive symptoms in obesity: a preliminary study I Delgado, S Cussotto, A Anesi, S Dexpert, A Aubert, B Aouizerate, ... International Journal of Obesity 46 (4), 885-888, 2022 | 16 | 2022 |
Tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in mice S Vancassel, H Fanet, N Castanon, CM De Oliveira, S Cussotto, ... Brain, Behavior, and Immunity 105, 139-148, 2022 | 11 | 2022 |
Psychotropic drugs and the microbiome S Cussotto, G Clarke, TG Dinan, JF Cryan Microbes and the Mind 32, 113-133, 2021 | 10 | 2021 |
The hippocampus and dorsal raphe nucleus are key brain areas associated with the antidepressant effects of lithium augmentation of desipramine S Cussotto, JF Cryan, OF O’Leary Neuroscience Letters 648, 14-20, 2017 | 5 | 2017 |
From gut to brain: Microbiota depletion in mice as a tool to explore causality S Cussotto, B Aouizerate, L Capuron Brain, behavior, and immunity 94, 4-5, 2021 | 4 | 2021 |
Probiotics in autism spectrum disorder: Recent insights from animal models N Golbaghi, S Naeimi, A Darvishi, N Najari, S Cussotto Autism, 13623613241246911, 2024 | 2 | 2024 |
P. 2.07 Differential effects of psychotropic drugs on microbiome composition S Cussotto, C Strain, F Fouhy, R Strain, V Peterson, T Bastiaanssen, ... Neurosci Biobehav Rev 74 (Pt A), 21-43, 2019 | 1 | 2019 |
Low omega-3 polyunsaturated fatty acid status predicts reduced response to standard antidepressants in patients with major depressive disorder S Cussotto, I Delgado, G Oriolo, J Kemper, D Begarie, S Dexpert, ... Brain, Behavior, and Immunity 98, 11, 2021 | | 2021 |
Differential effects of the gut microbiota on the pharmacokinetics of antipsychotic drugs J Walsh, S Cussotto, CR Strain, F Fouhy, C Stanton, TG Dinan, NP Hyland, ... NEUROGASTROENTEROLOGY AND MOTILITY 32, 2020 | | 2020 |
P. 585 Differential effects of psychotropic drugs on microbiome composition S Cussotto, C Strain, F Fouhy, R Strain, V Peterson, T Bastiaanssen, ... European Neuropsychopharmacology 29, S406-S407, 2019 | | 2019 |
Effects of psychotropic drugs on the microbiota-gut-liver-brain axis S Cussotto University College Cork, 2019 | | 2019 |